AI in Genomics Market Size, Growth Analysis, Technological Innovations, and Key Developments (2024-2032) | Impact of AI on Drug Discovery, Precision Medicine, Diagnostics, and Agricultural Applications with Forecasts

AI in Genomics Market Size and Growth Analysis

The AI in Genomics Market, as analyzed by MarketDigits, explores the impact of artificial intelligence across various sectors, including drug discovery, precision medicine, diagnostics, and agricultural applications.

The market is segmented by offering (software and services), functionality (such as genome sequencing, clinical workflows, and predictive genetic testing), and end-user (pharmaceutical, biotech companies, and others).

This forecast covers the period from 2024 to 2032, providing insights into the competitive index, partner and customer ecosystems, and regional footprints. The analysis also highlights technological trends shaping the industry's future, offering a comprehensive overview of growth opportunities.

The AI in Genomics Market is expected to be valued at USD 11.34 billion in 2024 and is projected to grow to USD 119.1 billion by 2030, registering a compound annual growth rate (CAGR) of 40% during the forecast period from 2024 to 2032.

Regional Insights:

North America is expected to dominate the AI in Genomics market, accounting for the largest share. This growth is driven by significant investments in AI and genomics, favorable government policies, and the presence of key industry players in the region.

In the United States, the AI in Genomics market is projected to grow from USD 0.11 billion in 2023 to an estimated USD 3.58 billion by 2033, marking a strong CAGR of 41.1%.

Get the Sample Research Report Copy on AI in Genomics Market: https://www.marketdigits.com/request/sample/1062

Why the Demand for AI in Genomics Has Increased in Recent Years

Advancements in Genomic Sequencing Technologies: The rapid progress in genomic sequencing technologies has generated vast amounts of complex data, requiring advanced tools to manage and analyze it effectively.

AI and machine learning algorithms are essential in processing this data, enabling researchers to derive meaningful insights more efficiently. AI applications are crucial in identifying gene-editing proteins and predicting molecular responses, which has accelerated the development of genetic therapies.

The integration of AI with genomic sequencing has thus become an indispensable tool in research and clinical applications.

Rising Demand for Precision Medicine: The growing shift towards personalized healthcare has significantly increased the need for AI in genomics. Precision medicine, which tailors treatment based on an individual's genetic makeup, relies heavily on AI to analyze genomic data and predict disease susceptibility and treatment outcomes.

AI-driven genomic analysis enhances the ability to offer personalized healthcare solutions, improving both the accuracy and efficiency of medical treatments. As the demand for precision medicine continues to rise, AI's role in genomics becomes even more crucial.

Integration of AI with CRISPR Technology: The integration of AI with CRISPR genome-editing technology has opened up new frontiers in genetic research and therapy development. AI facilitates the prediction of outcomes when editing genes, enhancing the safety and precision of genetic modifications.

This synergy between AI and CRISPR has accelerated research in genetic engineering, allowing for more effective treatments for various genetic diseases. The use of AI in optimizing CRISPR technology is driving innovation in genomic medicine.

Increased Investment in Genomic Research: The significant rise in investments dedicated to genomic research and AI integration has further fueled the growth of AI in genomics. Both private and public sectors are investing in advanced AI solutions to support genomic discoveries, diagnostics, and therapeutic advancements.

Increased funding from healthcare and technology companies has led to the rapid development of AI-based solutions that are transforming genomics research, which has, in turn, driven higher demand for AI technologies in the field.

Why the Demand for AI in Genomics is Expected to Increase in the Coming Years

Expansion of Genomic Databases: As the volume of genomic data continues to grow exponentially, the need for advanced tools to analyze and interpret this data becomes more pressing. AI plays a crucial role in managing and analyzing large genomic datasets, helping researchers make sense of the data and derive actionable insights.

The expansion of genomic databases, coupled with the increasing availability of high-quality genomic data, will continue to drive the demand for AI-powered solutions in genomics.

Advancements in AI Algorithms and Computational Power: With ongoing improvements in AI algorithms and computational power, the ability of AI systems to process complex genomic data has greatly enhanced. As these technologies evolve, AI will be better equipped to handle intricate datasets, providing more accurate, faster, and efficient results.

These advancements will broaden the application scope of AI in genomics, making it even more essential for research, diagnostics, and personalized treatment strategies.

Growing Focus on Rare Disease Research: AI is expected to play an increasingly pivotal role in identifying genetic variations related to rare diseases. By analyzing complex genomic data, AI can help researchers uncover insights that may not be apparent through traditional methods.

This is particularly important as rare diseases often have fewer data points and require advanced techniques for diagnosis and treatment. As the focus on rare disease research intensifies, the demand for AI in genomics is expected to rise significantly.

Get the complete view of 184 Pages Market Research Report on AI in Genomics: https://www.marketdigits.com/ai-in-genomics-market-1694155669

Innovations in AI-Driven Genomics by Leading Companies (2024-2025)

NVIDIA Corporation | Parabricks Suite

NVIDIA's Parabricks is a comprehensive suite of genomic analysis software designed to harness the power of GPU acceleration for high-throughput data processing. The software provides efficient workflows for DNA and RNA analysis, focusing on the detection of germline and somatic mutations.

Parabricks is fully compatible with open-source genomic tools, ensuring high accuracy and scalability.

The latest version (4.3.1-1) introduces support for NVIDIA's Grace Hopper super chip, boosting the performance of genomic applications by utilizing both GPUs and CPUs.

Microsoft | Azure for Genomics

Microsoft has enhanced its Azure cloud platform to offer specialized services aimed at genomic data analysis. By integrating AI with Azure's robust cloud infrastructure, researchers and healthcare providers are empowered to efficiently process and interpret large genomic datasets.

These advancements enable the development of personalized healthcare solutions, making it easier to leverage genomic data in clinical settings.

Azure's AI capabilities streamline the interpretation of complex data, accelerating progress in genomic medicine.

IBM | Watson for Genomics

IBM has expanded its Watson for Genomics platform with cutting-edge AI technologies to provide more accurate and efficient genomic data analysis.

The platform aids in the identification of genetic mutations and the creation of tailored treatment plans by leveraging machine learning to interpret complex genomic information.

Watson for Genomics accelerates the process of understanding genetic data, playing a crucial role in advancing precision medicine and helping healthcare professionals offer more personalized treatment options.

BenevolentAI | AI-Driven Drug Discovery

BenevolentAI has strengthened its collaboration with AstraZeneca to apply AI in drug discovery, focusing on the analysis of genomic data to identify potential therapeutic targets.

This partnership is set to speed up the development of new treatments by leveraging AI to uncover insights from complex genomic information.

BenevolentAI's platform uses machine learning algorithms to analyze genomic data, enhancing the discovery of novel drug candidates and biomarkers for targeted therapies.

Thermo Fisher Scientific | Cloud-Based Genomic Analysis

Thermo Fisher Scientific, in partnership with Google Cloud, has integrated AI and cloud computing into genomic research to accelerate scientific breakthroughs.

This collaboration enables the development of AI-powered solutions for genomic data analysis, aimed at accelerating the discovery of personalized treatments.

Thermo Fisher's cloud-based tools leverage AI to interpret and process large-scale genomic datasets, providing researchers and healthcare providers with powerful insights that drive advancements in genomic medicine.

Get a Discount on the Premium Research Report on AI in Genomics Market: https://www.marketdigits.com/request/discount/1062

FAQs on AI in Genomics Market

How Big is the AI in Genomics Market?
The AI in Genomics market was valued at approximately USD 11.34 billion in 2024. It is expected to grow significantly, reaching a projected value of USD 119.1 billion by 2030, with a compound annual growth rate (CAGR) of 40% from 2024 to 2032.

This substantial growth highlights the increasing adoption of AI technologies in genomic research and personalized medicine applications. (GlobeNewswire)

How is AI Used in Genomics?
AI is revolutionizing genomics by streamlining the analysis and interpretation of complex genetic data. Some key applications include:

Data Analysis and Interpretation: AI algorithms process large genomic datasets to identify genetic variations, mutations, and patterns, enabling deeper insights into genetic information.

Predictive Modeling: AI models predict future genomic variations, supporting public health initiatives and accelerating the development of vaccines, as seen with SARS-CoV-2 and influenza strains.

Integration of Diverse Data Types: AI integrates genomic, clinical, environmental, and lifestyle data, aiding the development of personalized treatment plans and enhancing precision medicine.

What is the Future of Genomics with AI?
The future of genomics with AI is promising, with AI poised to play a transformative role in several key areas:

Personalized Medicine: AI will enable the development of individualized treatment plans based on a person's genetic makeup, ensuring more effective and tailored healthcare.

Accelerated Drug Discovery: AI-driven genomic data analysis will speed up the process of identifying therapeutic targets, facilitating faster and more cost-effective drug development.

Enhanced Disease Prediction and Prevention: AI will assist in predicting genetic predispositions to diseases, enabling early intervention and preventive measures.

Is AI in Genomics a Growing Field?
Yes, AI in genomics is a rapidly growing field. The market is witnessing impressive expansion, with an expected CAGR of 40% from 2024 to 2032.

The integration of AI technologies in genomics is enabling groundbreaking advancements in precision medicine, drug discovery, and genetic data analysis.

Other Trending Reports

Antibody Discovery Market: https://www.marketdigits.com/antibody-discovery-market-1701437022

Medical Batteries Market: https://www.marketdigits.com/medical-batteries-market-1701869386

Non-CRISPR Genome Editing Therapy Market: https://www.marketdigits.com/non-crispr-genome-editing-therapy-market-1701869386

Ocular Drug Delivery System Market: https://www.marketdigits.com/ocular-drug-delivery-system-market-1701869386

Organ-on-a-Chip Market: https://www.marketdigits.com/organ-on-a-chip-market-1701869386

Subcutaneous Biologics Market: https://www.marketdigits.com/subcutaneous-biologics-market-1701869386

TCR Therapy Market: https://www.marketdigits.com/tcr-therapy-market-1701869386

TIL Therapy Market: https://www.marketdigits.com/til-therapy-market-1701869386

Womens Digital Health Market: https://www.marketdigits.com/womens-digital-health-market-1701869386

Bioassay Services Market: https://www.marketdigits.com/bioassay-services-market-1701869386

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.